Johnson & Johnson reported $10.99B in Stock for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Amgen AMGN:US $ 4554M 143M
Baxter International BAX:US $ 2663M 115M
Bayer BAYN:GR € 11371M 502M
Becton, Dickinson and BDX:US $ 3163M 95M
Biogen BIIB:US $ 1294.2M 78.8M
Bristol Myers Squibb BMY:US $ 2142M 38M
Cardiovascular Systems CSII:US $ 34.57M 1.71M
Cooper Companies COO:US $ 621.6M 17.8M
Dexcom DXCM:US $ 339.5M 2.7M
Edwards Lifesciences EW:US $ 740M 9.4M
Eli Lilly And LLY:US $ 3899.4M 6.4M
Gilead Sciences GILD:US $ 2587M 88M
GlaxoSmithKline GSK:LN 466400M 133900M
Globus Medical GMED:US $ 266.04M 12.16M
Insulet PODD:US $ 320.4M 5.6M
Intuitive Surgical ISRG:US $ 724M 71M
Medtronic MDT:US $ 4809M 193M
Novartis NOVN:VX SF 6880M 117M
Nuvasive NUVA:US $ 331.71M 7.3M
Regeneron Pharmaceuticals REGN:US $ 2218.5M 227M
Stryker SYK:US $ 3749M 224M
Teva Pharmaceutical TEVA:IT 4.05B 37M
Vertex Pharmaceuticals VRTX:US $ 367.7M 28.8M
Zimmer Biomet Holdings Inc ZBH:US $ 2.12B 9.4M
Zoetis ZTS:US $ 2205M 148M